Dec 16 2008
In a significant decision, the Supreme Court of Canada (Apotex Inc. v. Sanofi-Synthelabo Canada et al (2008 SCC 61)) upheld pharmaceutical selection patents but defined potentially more stringent tests for anticipation and obviousness.
Read the complete article at Law 360.
This article is for information purposes only and does not constitute legal or professional advice.
Back to blog overview
Tags: IP Law 360, Patents, Pharmaceutical